Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
7 p, 813.8 KB Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions / Cohen, Jeffrey A. (Mellen Center, Neurologic Institute, Cleveland Clinic) ; Bermel, Robert (Mellen Center, Neurologic Institute, Cleveland Clinic) ; Grossman, Cynthia I. (Biogen, Cambridge) ; Hersh, Carrie (Cleveland Clinic (Las Vegas)) ; Hyland, Megan. (University of Rochester. Department of Neurology) ; Mowry, Ellen M. (Johns Hopkins University. Department of Neurology) ; Naismith, Robert (Washington University in St. Louis. Department of Neurology) ; Naylor, Maria L. (Biogen, Cambridge) ; Nicholas, Jacqueline (OhioHealth Multiple Sclerosis Center) ; Rajbhandar, Rajani (Biogen, Cambridge) ; Singh, Carol M. (Biogen, Cambridge) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron) ; Ziemssen, Tjalf (University Clinic Carl-Gustav Carus. Department of Neurology) ; Williams, James R. (Biogen, Cambridge) ; Montalban, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina)
The impact of multiple sclerosis (MS) disease-modifying therapies (DMTs) on SARS-CoV-2 vaccination response is uncertain. Post-SARS-CoV-2 vaccination blood samples across multiple DMTs were tested for SARS-CoV-2 immunoglobulin G (IgG) response. [...]
2022 - 10.1177/13524585211061343
Multiple sclerosis, Vol. 28 Num. 7 (january 2022) , p. 1131-1137  
2.
15 p, 865.1 KB Harnessing Real-World Data to Inform Decision-Making : Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) / Mowry, Ellen M. (Johns Hopkins University) ; Bermel, Robert (Cleveland Clinic) ; Williams, James R. (Biogen) ; Benzinger, Tammie L. S. (Washington University in St. Louis) ; de Moor, Carl (Biogen) ; Fisher, Elizabeth (Biogen) ; Hersh, Carrie M. (Cleveland Clinic Lou Ruvo Center for Brain Health) ; Hyland, Megan H. (University of Rochester Medical Center) ; Izbudak, Izlem (Johns Hopkins University) ; Jones, Stephen E. (Cleveland Clinic) ; Kieseier, Bernd C. (Biogen) ; Kitzler, Hagen H. (University Clinic Carl Gustav Carus, TU Dresden) ; Krupp, Lauren (New York University) ; Lui, Yvonne W. (New York University) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Naismith, Robert T. (Washington University in St. Louis) ; Nicholas, Jacqueline A. (OhioHealth) ; Pellegrini, Fabio (Biogen) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Schulze, Maximilian (University Hospital of Giessen and Marburg (Alemanya)) ; Tackenberg, Björn (University Hospital of Giessen and Marburg (Alemanya)) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Tivarus, Madalina E. (University of Rochester Medical Center) ; Ziemssen, Tjalf (Center of Clinical Neuroscience, University Clinic Carl Gustav Carus, TU Dresden) ; Rudick, Richard A. (Biogen) ; Universitat Autònoma de Barcelona
Background: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) is the first example of a learning health system in multiple sclerosis (MS). This paper describes the initial implementation of MS PATHS and initial patient characteristics. [...]
2020 - 10.3389/fneur.2020.00632
Frontiers in neurology, Vol. 11 (august 2020)  
3.
9 p, 776.0 KB Multiple sclerosis management during the COVID-19 pandemic / Moss, Brandon P. (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Mahajan, Kedar R. (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Bermel, Robert (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Hellisz, Kelsey (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Hua, Le H. (Lou Ruvo Center for Brain Health, Cleveland Clinic) ; Hudec, Timothy (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Husak, Scott (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; McGinley, Marisa P. (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Ontaneda, Daniel (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Wang, Zhini (Department of Quantitative Health Sciences, Cleveland Clinic) ; Weber, Malory (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Tagliani, Paula (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cárdenas-Robledo, Simón (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodríguez-Barranco, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Douglas, Morgan (Division of Neuroimmunology and Neurological Infections, Johns Hopkins University) ; Ogbuokiri, Esther (Division of Neuroimmunology and Neurological Infections, Johns Hopkins University) ; Aravidis, Berna (Division of Neuroimmunology and Neurological Infections, Johns Hopkins University) ; Cohen, Jeffrey A. (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Mowry, Ellen M. (Division of Neuroimmunology and Neurological Infections, Johns Hopkins University) ; Fitzgerald, Kathryn C. (Division of Neuroimmunology and Neurological Infections, Johns Hopkins University) ; Universitat Autònoma de Barcelona
People with multiple sclerosis (MS) may be at higher risk for complications from the 2019 coronavirus (COVID-19) pandemic due to use of immunomodulatory disease modifying therapies (DMTs) and greater need for medical services. [...]
2020 - 10.1177/1352458520948231
Multiple sclerosis, August 2020  

See also: similar author names
1 Mowry, Ellen
3 Mowry, Ellen M.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.